India's Venus Remedies surges on renewing EU certificate for Portugal plant
21/01/2025 04:32
** Venus Remedies' stock VENR.NS jump as much as 12.5% to
332.4 rupees; biggest intraday gain since mid-June
** Stock last up ~8% after pharma co renews European Good
Manufacturing Practices (GMP) certification for Portugal plant
** Stock on track to log busiest trading session since
early-Dec, with volume 3.5x the 30-day avg
** It lost ~22% in 2024 vs 124% gains in 2023
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))
Recent news on Venus Remedies
See all newsBrief: Venus Remedies Sept-Quarter Consol Net Profit 256.5 Million Rupees
Brief: Venus Remedies Secured Five Marketing Authorisations Across Kazakhstan, Peru, Kuwait And Argentina
India's Venus Remedies rises after quarterly profit more than doubles
Brief: Venus Remedies June-Quarter Consol Net Profit 229.7 Million Rupees
India raises price cap on cancer drugs to tackle shortage